Skip to main content

Table 2 Mutual exclusivity analysis of target genes

From: Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy

A

B

Log2 Odds Ratio

p-Value

Tendency

ADIPOQ

CD36

>  3

0.017

Co-occurrence

Back to article page

BMC Genomic Data

ISSN: 2730-6844

Contact us